Business Context and Reporting Period
This Form 8-K is a current report filed by The Clorox Company (CLX) on June 14, 2026. The filing discloses significant executive leadership appointments and associated compensatory arrangements effective June 17, 2026.
Key Financial Metrics
The filing does not provide financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on executive compensation details:
- Chris Hyder (New COO): Base salary increased to $800,000; short-term incentive target increased to 100% of salary; granted restricted stock units (RSUs) with an aggregate fair value of $4,000,000 vesting over three years.
- Nina Barton (New Chief Growth & Strategy Officer): Appointed to new role; specific compensation figures for this appointment are not detailed in this filing.
Material Changes
The primary material change is the restructuring of the executive leadership team:
- Chris Hyder appointed as Executive Vice President and Chief Operating Officer (COO).
- Nina Barton appointed as Executive Vice President and Chief Growth & Strategy Officer, transitioning from her previous role as Group President – Care & Connection.
Guidance, Outlook, and Risks
The filing contains no financial guidance, outlook, or management commentary regarding future business performance. No specific risks or contingencies are disclosed in this report, other than the standard disclosure that no familial relationships or related party transactions exist for the appointed officers.
Investor Verification Checklist
- Verify the vesting schedule and performance conditions for Chris Hyder's $4,000,000 RSU grant.
- Review the referenced 2025 Form 10-K for detailed background on the previous roles of Chris Hyder and Nina Barton.
- Confirm the effective date of the new roles (June 17, 2026) against internal corporate calendars.
- Check for any subsequent filings regarding the departure of the previous COO or Chief Growth & Strategy Officer.